New patent for Gilead Sciences drug EPCLUSA

Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are fifteen…
The post New patent for Gilead Sciences drug EPCLUSA appeared first on DrugP…


New patent expiration for Novartis drug AMTURNIDE

Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. This drug has one…
The post New patent expiration for Novartis drug AMTURNIDE appeared first o…


Biotechblog